South Korea tightens medical device quality and distribution rules for 2026

South Korea is amending its Medical Device Act on July 1, 2026, to establish a stronger, formalized legal basis for its Quality Management System Conformity Recognition Scheme. Overseen by the Ministry of Food and Drug Safety, the new regulations will tighten oversight across the entire medical device supply chain. Importers, distributors, and rental businesses will be legally required to maintain highly detailed tracking records for all devices. Additionally, any affected business that plans to close or suspend its operations for more than one month must report this change directly to the Ministry of Food and Drug Safety.

For clinical business owners, these changes are highly relevant if you source aesthetic technologies, laser systems, or injectables directly from South Korean manufacturers. The regulatory shift means your suppliers will face much stricter compliance audits and tracing requirements. While this promises to improve long-term supply chain integrity and device safety, it could temporarily disrupt shipping timelines or administrative workflows during the transition period. If you rely on Korean imports for your practice, you should verify with your distributors that their quality systems and reporting protocols are prepared for the new mandate.

Source: Apple Podcasts / Pure Global, https://podcasts.apple.com/us/podcast/south-korea-medical-device-act-2026-mfds-qms-and-distribution/id1721528657?i=1000755734892